Compare Cytokinetics Inc (CYTK) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs DexCom, Inc. — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while DexCom, Inc. trades at $89.2 (market cap $33.79B). The key difference: DexCom, Inc. is far larger — about 3.2× Cytokinetics Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals.
| CYTK | DXCM | |
|---|---|---|
Market Cap | $10.63B | $33.79B |
Sector | Technology | Health |
52-Week High | $87.26 | $89.53 |
52-Week Low | $34.31 | $54.84 |
Enterprise Value | $10.74B | $33.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
